- Home
- NVNI vs LTRN Comparison
NVNI vs LTRN Comparison
Compare NVNI & LTRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NVNI
- LTRN
- Stock Information
- Founded
- NVNI 2019
- LTRN 2013
- Country
- NVNI Brazil
- LTRN United States
- Employees
- NVNI N/A
- LTRN N/A
- Industry
- NVNI
- LTRN Biotechnology: Pharmaceutical Preparations
- Sector
- NVNI
- LTRN Health Care
- Exchange
- NVNI Nasdaq
- LTRN Nasdaq
- Market Cap
- NVNI 57.2M
- LTRN 49.9M
- IPO Year
- NVNI N/A
- LTRN 2020
- Fundamental
- Price
- NVNI $3.23
- LTRN $3.51
- Analyst Decision
- NVNI
- LTRN Strong Buy
- Analyst Count
- NVNI 0
- LTRN 1
- Target Price
- NVNI N/A
- LTRN $25.00
- AVG Volume (30 Days)
- NVNI 274.9K
- LTRN 118.0K
- Earning Date
- NVNI 09-30-2025
- LTRN 11-13-2025
- Dividend Yield
- NVNI N/A
- LTRN N/A
- EPS Growth
- NVNI N/A
- LTRN N/A
- EPS
- NVNI N/A
- LTRN N/A
- Revenue
- NVNI $31,250,627.00
- LTRN N/A
- Revenue This Year
- NVNI $12.05
- LTRN N/A
- Revenue Next Year
- NVNI $15.02
- LTRN N/A
- P/E Ratio
- NVNI N/A
- LTRN N/A
- Revenue Growth
- NVNI 1491.58
- LTRN N/A
- 52 Week Low
- NVNI $1.44
- LTRN $2.55
- 52 Week High
- NVNI $121.90
- LTRN $6.12
- Technical
- Relative Strength Index (RSI)
- NVNI 51.43
- LTRN 37.02
- Support Level
- NVNI $3.17
- LTRN $3.75
- Resistance Level
- NVNI $3.47
- LTRN $4.09
- Average True Range (ATR)
- NVNI 0.32
- LTRN 0.29
- MACD
- NVNI -0.17
- LTRN -0.06
- Stochastic Oscillator
- NVNI 13.76
- LTRN 35.61
About NVNI Nvni Group Limited
Nvni Group Ltd is a holding company that conducts all of its business through Nuvini SA and Nuvini acquired companies. Nuvini S.A. acquires and operates software companies within SaaS markets in Brazil. Nuvini S.A. is the private serial software business acquirer in Brazil and intends to use funding and capital markets access to continue expanding its acquisition plans in Brazil and Latin America. The Company has determined that it has a single operating and reportable segment which is multi-vertical SaaS solution model.
About LTRN Lantern Pharma Inc.
Lantern Pharma Inc is an AI company transforming the cost, pace, and timeline of oncology drug discovery and development. Its proprietary AI and machine learning (ML) platform, RADR, uses oncology-focused data points and advanced ML algorithms to solve billion-dollar, real-world problems in cancer drug development. The group's growing pipeline of precision therapies has been accelerated using AI and input from world-class scientific advisors and collaborators.